FDA Inspection 729481 — SPI Pharma, Inc.
The FDA completed an inspection of SPI Pharma, Inc. on May 4, 2011 in Grand Haven, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 4, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Grand Haven, MI (United States)